Accelerate Diagnostics

Dec 26, 2018

GenMark Fungal Blood Culture Test Clears FDA

The test is the second of three panels intended to detect pathogens that cause the bloodstream infections that can lead to sepsis.

Aug 23, 2018

Luminex Verigene MDx Panel Speeds Up AST, Reduces Cost, Study Finds

Premium

Clinicians identifying and treating S. aureus bloodstream infections reduced the median length of stay by 5.6 days and hospital cost by $13,341 per patient after using Luminex's assay.

Jun 15, 2017

FDA Clearance for GenMark's ePlex Intensifies Competition in Highly Plexed MDx Test Market

Premium

The firm will encounter stiff competition, particularly from BioMérieux and Luminex, but there are untapped opportunities for adoption, according to industry analysts.

Sep 16, 2016

Sepset Biosciences Developing Sepsis Test Based on Cellular Reprogramming Signature

Premium

The test is based on a biomarker signature that consists of a core set of 31 genes associated with endotoxin tolerance in sepsis patients.

Jul 22, 2016

Speed and Accuracy Top Considerations for Lab Directors in Choosing Sepsis Dx

Premium

Despite the array of tests available, some lab directors are still seeking broader functionalities and capabilities from the systems they purchase.

Jul 13, 2016

Accelerate Diagnostics' Pathogen ID, Antimicrobial Susceptibility Platform Moves Closer to Market

Premium

The company's test kit can ID pathogenic organisms and provide a measure of antibiotic susceptibility directly from positive blood culture samples.

Jul 11, 2016

Accelerate Diagnostics Submits Molecular, Phenotypic Detection Technologies for FDA Evaluation

The company's test kit provides identification and antimicrobial susceptibility testing of pathogens for patients suspected of bacteremia or fungemia.

Jan 29, 2016

District Court Dismisses Shareholders' Lawsuit Against Accelerate Diagnostics

The US District Court for the District of Arizona has granted Accelerate Dx's motion to dismiss a class-action lawsuit filed against it last year.

Aug 03, 2015

Accelerate Dx Posts Increase in Q2 Revenues, Net Loss

The firm's revenues nominally increased due to licensing agreements, while expenses also increased as the company ramps up its R&D efforts.

Jul 01, 2015

Accelerate Dx Lands CE Mark for ID/AST System, Initiates Clinical Trial Enrollment

The regulatory activity for the diagnostic platform follows ISO 13485:2003 certification in March. The firm is also planning a 510(k) submission to the FDA.

Pages

Breaking News

The Scan

Concerns About Bias in Policies

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Reprogrammable DNA

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Lack of Diversity

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

This Week in Science

In Science this week: whole-genome sequencing of single sperm cells, and more.